Introduction
============

The Shuttle Walking Test (SWT) has been previously shown to correlate well with patients\' maximal oxygen uptake (VO~2~max) \[[@B1]-[@B3]\]. Older and colleagues demonstrated that an anaerobic threshold of 911 ml/min/kg, in patients undergoing major abdominal surgery, was an excellent predictor of mortality from cardio-respiratory causes \[[@B4]\]. Patients undergoing oesophagogastric surgery currently have a 30-day mortality of approximately 9% in our institution and are all admitted to critical care postoperatively. Our aim was to assess the value of a preoperative SWT in trying to identify high-risk patients.

Method
======

All patients listed for oesophagogastrectomy between April 2002 and September 2004 undertook a SWT as a standard part of their preoperative assessment. Routine anaesthesia, surgery and critical care was provided guided by clinical requirements. Thirty-day mortality was compared retrospectively with shuttle test data.

Results
=======

Thirty-nine patients undertook a SWT, and had surgery. The mean age of the group was 64 years (range 44--81 years). The mean SWT distance was 480 m (range 220--880 m). At the 30th postoperative day, 18 patients had been discharged home (46.2%), 14 patients remained on the wards (35.9%), three still required critical care (7.7%) and four patients had died (10.2%). No patient with a SWT of greater than 350 m died within 30 days of surgery. Patients with a SWT of 350 m and below had a 50% 30-day mortality.

Discussion
==========

This small patient group appears to be representative of the oesophagogastric surgical population within our institution (mortality 10.2% vs 9%). A SWT of 350 m appears to be a sensitive marker of increased postoperative mortality in this particular patient population. This finding is consistent with Lewis and colleagues\' \[[@B2]\] data correlating SWT distance with VO~2~max and Older and colleagues\' \[[@B4]\] work on the anaerobic threshold and perioperative outcome. Further evaluation is required, but using this simple, cheap and reliable non-invasive preoperative test may help to risk-stratify patients undergoing high-risk surgery. High-risk groups may benefit from appropriately informed consent for surgery but potentially also from preoperative cardiopulmonary training and a focused utilisation of resources.
